Bausch + Lomb (NYSE: BLCO), an eye health and contact lens maker, says it won't pursue a take-private, but it still aims to separate from majority owner Bausch Health (NYSE: BHC).
Why it matters: The separation process is going on its fifth year, with shareholders and lenders at odds amid $20 billion in debt.
